Overview
A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2022-03-01
2022-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the study is to investigate the role of SB 8.4% as adjuvant therapy in the treatment of COVID- 19 patients proved to be RT-PCR positive (mild, moderate and severe).Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Mansoura University
Criteria
Inclusion Criteria:- all consecutive patients suspected as COVID-19 presented to the respiratory evaluation
zone and outpatient clinic of our university will be subjected to RT-PCR test for
COVID.
- Patients proved to be RT-PCR positive will be included in the present study.
Exclusion Criteria:
- pregnant ladies
- who will refuse enrollment or discontinue follow up.